MALT cells accumulate in liver fibrotic septa in patients suffering from NAFLD-related cirrhosis and exhibit a pro-inflammatory phenotype with increased IL-17+ T cells. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.